semaglutide containing products Novo Nordisk medicines GLP-1 Weight Loss Options |

Oxford University Press p

Night Sweats Increased thermogenesis from glucagon receptor activation can occasionally manifest as night sweats, particularly during the first month of treatment

The lower concentration spreads the dose range across more syringe units, giving finer control during titration

This product is: Not approved for human consumption Not intended for veterinary use Not a medicine or therapeutic product Not intended as a weight-loss treatment Not intended to diagnose, treat, cure or prevent any disease All research compounds should be handled by appropriately qualified personnel in accordance with applicable laboratory procedures and regulations